Kinfe Ken Redda, Ph.D.Professor Emeritus in Medicinal Chemistry Pharmaceutical Sciences
The overall scope of the research activities encompasses the design and synthesis of effective medicinal agents. The main goal is to develop safe and effective drugs that can be used for the treatment of breast cancer.
M. Gangapuram, E. Mazzio, S. Eyunni, K. F. A. Soliman and K. K. Redda*, “Synthesis and Biological Evaluation of Substituted N-[3-(1H-Pyrrol-1-yl)methyl]-1,2,5,6-tetrahydropyridin-1yl]benzamide/benzene Sulfonamides as Anti-Inflammatory Agents”, Arch. Pharm. Chem. Life Sci. 2014, 347, 360-369. PMID: 24585402.
Suresh VK, Madhavi G, Redda KK*., “In-vitro Antiproliferative Activity of New Tetrahydroisoquinolines (THIQs) on Ishikawa Cells and their 3D Pharmacophore Models”, Letters in Drug Design & Discovery, 2014, 11 (4), 428-436. NIHMS ID: NIHMS580134.
Madhavi Gangapuram, Suresh Eyunni, Kinfe K. Redda, Synthesis and Pharmacological evolution of Tetrahydroisoquinolines as Anti Breast Cancer Agents. J. Cancer Sci. Ther. 6, 161-169, (2014). NIHMSID: 610855.
Nelly Mateeva, Madhavi Gangapuram, Elizabeth Mazzio, Suresh Eyunni, Karam F.A. Soliman, Kinfe K. Redda*, “Biological Evaluation of Synthetic Chalcone and Flavone derivatives as Anti-inflammatory Agents”, Medicinal Chemistry Research, 2015, 24(4), 1672-1680.